JACOBS LEVY EQUITY MANAGEMENT, INC - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 222 filers reported holding SEATTLE GENETICS INC in Q2 2015. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q1 2018$3,769,000
-35.8%
72,010
-34.4%
0.06%
-38.8%
Q4 2017$5,875,000
+97.7%
109,810
+101.1%
0.10%
+77.6%
Q3 2017$2,971,000
+1000.4%
54,600
+609.1%
0.06%
+866.7%
Q1 2016$270,000
-31.6%
7,700
-12.5%
0.01%
-25.0%
Q4 2015$395,000
-24.0%
8,800
-18.1%
0.01%
-20.0%
Q2 2015$520,000
-80.5%
10,750
-85.7%
0.01%
-77.8%
Q1 2015$2,662,000
-73.1%
75,290
-75.5%
0.04%
-73.4%
Q4 2014$9,890,000
+1641.2%
307,800
+1914.4%
0.17%
+1777.8%
Q3 2014$568,00015,2800.01%
Other shareholders
SEATTLE GENETICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Baker Brothers Advisors 50,060,240$5,775,950,00035.57%
Lagoda Investment Management, L.P. 72,969$8,419,0009.97%
Avidity Partners Management LP 580,000$66,920,0009.25%
Arabesque Asset Management Ltd 14,807$1,708,0003.53%
Boxer Capital, LLC 400,000$46,152,0003.15%
Woodline Partners LP 364,333$42,037,0003.00%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 56,900$6,557,0002.99%
SECTORAL ASSET MANAGEMENT INC 107,000$12,346,0002.37%
Capital International, Inc./CA/ 1,197,659$138,186,0002.33%
Bain Capital Public Equity Management II, LLC 169,641$19,573,0002.29%
View complete list of SEATTLE GENETICS INC shareholders